• United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on July 29, 2026.
• Family trust sold 9,500 shares the same day at about USD 518.25 to USD 525.46.
• Trust’s common stock holdings fell to 324,443 shares following the sales.
• Trust held 246,410 stock options after the exercise.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000109), on July 30, 2026, and is solely responsible for the information contained therein.